NLS Pharmaceutics Secures Patent for Dual Orexin Receptor Agonists
The new patent application from Aexon Labs, licensed to NLS Pharmaceutics, covers dual orexin receptor agonists designed to treat narcolepsy.
Source: sleepreviewmag.com
Pharmaceutics Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharmaceutics Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharmaceutics Ltd Today - Breaking & Trending Today
NLS Pharmaceutics AG: NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol's Neuroprotective Effects in Narcoleptic-like Rat Model
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 28, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to pioneering therapies
Source: finanznachrichten.de
NLS Pharmaceutics Challenges Nasdaq Delisting
Nls Pharmaceutics Ltd (NLSP) has released an update. NLS Pharmaceutics Ltd., a Swiss biopharmaceutical company, is set to appeal a delisting notice...
Source: biztoc.com
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination ...
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination ...
Source: pr-inside.com
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request
ZÜRICH, SWITZERLAND / ACCESSWIRE / April 19, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sys...
Source: pharmiweb.com